Physician profile

Matthew B Sellers

Clinical Cardiac Electrophysiology · Greenville, SC

NPI 1528225356

$31,037.50

in general payments reported to CMS, 2019-2025

38 companies · $1,701 in 2025

The $1,701 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$5,687.23
Travel and Lodging$1,900.82

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Janssen Pharmaceuticals, INC $14,240.85 2019-2023 Xarelto
Biosense Webster, INC. $4,406.00 2019-2025 Carto 3, Soundstar
Boston Scientific Corporation $4,289.51 2019-2025 Watchman Flx, Farapulse, Watchman Access System
Biotronik INC. $2,741.60 2019-2025 Acticor 7 Vr-T Dx, Amvia Edge, Selectra
Medical Device Business Services, INC. $957.48 2024 Carto 3
Cardiva Medical, INC. $909.06 2020-2025 Cardiva Vascade Mvp Vvcs 6-12f
Abbott Laboratories $760.44 2019-2024 Confirm Rx, Aveir
Atricure, INC. $371.52 2022-2025 Epi-Sense Guided Coagulation System With Visitrax
Novartis Pharmaceuticals Corporation $354.90 2019-2023
Medtronic, INC. $323.42 2021-2025 Micra, Symplicity G3, Onyx Frontier
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $311.04 2019-2025 Lifevest
Amgen INC. $251.95 2019-2023 Repatha
Sanofi-Aventis U.S. LLC $136.72 2019
Merit Medical Systems INC $131.98 2023 Worley Adv Coronary Sinus Guide, Safeguard Focus
Edwards Lifesciences Corporation $111.09 2019
Show all 38 companies
CompanyGeneral paymentsYearsTop products
Pfizer INC. $108.40 2021-2025
Boehringer Ingelheim Pharmaceuticals, INC. $77.28 2019-2023 Jardiance
Medtronic Vascular, INC. $53.33 2019-2020
Astrazeneca Pharmaceuticals Lp $50.62 2020-2022
Amarin Pharma, INC. $43.61 2020-2023
Impulse Dynamics (USA) INC. $38.88 2022
Elutia, INC. $38.02 2022-2024 Ecm Patch,Pouch
Bayer Healthcare Pharmaceuticals INC. $37.73 2022-2023
Merck Sharp & Dohme LLC $35.84 2021-2022
Kestra Medical Technology Services, INC. $33.00 2023 Assure Wcd
E.R. Squibb & Sons, L.L.C. $25.30 2019-2022
Philips North America LLC $23.65 2025 Ambulatory Monitoring & Diagnostics Undivided
Lundbeck LLC $21.98 2019
Becton, Dickinson and Company $20.98 2025 Hemosphere
Cmp Pharma, INC. $19.42 2022
Cvrx, INC. $18.15 2023 Barostim Neo System
Kiniksa Pharmaceuticals, Ltd. $17.40 2022
Shockwave Medical, INC $16.76 2025
Scpharmaceuticals INC. $16.50 2023
Cardiovascular Systems INC. $15.31 2019
Terumo Medical Corporation $12.59 2022
Bardy Diagnostics, INC. $10.00 2020
Catheter Precision INC. $5.19 2023

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Matthew B Sellers

$31,037.50

in general payments reported 2019-2025

Years
2019-2025
Top company
Janssen Pharmaceuticals, INC
Context
The $1,701 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).

https://glasscript.com/doctor/295613/matthew-b-sellers

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.